NASDAQ NMS - GLOBAL MARKET · KMDA
+0.00% · +$0.0000 · Vol 25.8K
Kamada Ltd

Kamada Ltd

Biotechnology
$7.44
+ Add to watchlist
Card

Veridion Score

Loading
Score loading…
Veridion Score History · 90D

Composite trend over time

LOADING HISTORY…
REFRESHES DAILY
AI Analysis
Sovereign

Why is KMDA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Kamada Ltd
Biotechnology
Founded
—
Listed
2013
Employees
462
HQ
IL

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Company website →
Key statistics

Real vendor fields plus Veridion-computed history. Missing fields stay blank.

Open
$7.42
Day high
$7.50
Day low
$7.42
Previous close
$7.44
52W high
$7.50
-0.80% from high
52W low
$7.21
79% of range
Market cap
$429.2M
P/E
—
EPS
—
Dividend yield
—
Beta
—
Shares out
57.7M
Float
—
Volume
25.8K
Avg volume
—
VWAP
$7.46
Next earnings
—
Price history computed in-house
1W
+3.19%
1M
+3.19%
3M
+3.19%
1Y
+3.19%
YTD
+3.19%
SMA 50 $7.36 · above
SMA 200 $7.36 · above
52W position 79%
Veridion warehouse edge

Warehouse intelligence for KMDA.

Veridion Score
44
0: 651: 442: 413: 204: 815: 60
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
—
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Loading quarterly statements…
SEC Form 4 ledger

KMDA insider activity

Kamada Ltd

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
$0
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: $0 across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for KMDA.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Loading PTR filings…
Federal contracts

KMDA contract awards, year to date.

Public federal awards linked to this ticker.

—
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for KMDA in this window.
Lobbying spend

KMDA lobbying filings, year to date.

Registered lobbying filings matched to Kamada Ltd.

—
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for KMDA in this window.
Latest news · KMDA
Refresh interval: 5 minutes · Source: Market news insights
Loading articles…
Analyst ratings
Sovereign unlock shows live analyst consensus for KMDA.
Options
Sovereign unlock shows live options positioning for KMDA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.